Schedule Dispatches

Schedule dispatches give a summary of changes coming out in the next month.

On this page

Kia ora

This is an early notification of the changes to be announced in the Update to the Pharmaceutical Schedule.

The full Update will be available as a PDF on our website.(external link)

The changes will be published in the online Schedule around the 23rd of this month and are effective from next month.

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.

March 2024

New Listings

  • Clomipramine hydrochloride (Clomipramine – Teva) cap 10 mg – safety medicine, s29 and wastage claimable (p’code 2674149)
  • Ezetimibe (Ezetimibe Viatris) tab 10 mg (p’code 2488744)
  • Fluorouracil (Fluorouracil Accord) inj 50 mg per ml, 50 ml vial – PCT only – Specialist (p’code 2674092)
  • Hyoscine hydrobromide (Scopolamine – Mylan) patch 1 mg per 72 hours – Special Authority – Retail pharmacy, s29 and wastage claimable (p’code 2674181)
  • Lidocaine [Lignocaine] hydrochloride (Xylocard 500) inj 10%, 5 ml ampoule, CBS – Subsidy by endorsement, s29 (p'code 2674351)
  • Meningococcal B multicomponent vaccine (Bexsero) inj 175 mcg per 0.5 ml prefilled syringe, 10 inj pack – only on a prescription, no patient co-payment payable and access criteria apply (p’code 2671948)
  • Olanzapine (Zypine) tab 2.5 mg, 5 mg and 10 mg, 30 tab pack - safety medicine (p’code 2651076, 2651084 and 2651092 respectfully)
  • Paclitaxel (Anzatax) inj 6 mg per ml, 16.7 ml vial – PCT only – Specialist (p’code 2271834)
  • Pharmacy services (BSF Noumed Dexamfetamine) brand switch fee – may only be claimed once per patient (p’code 2673886)
  • Phenobarbitone (Noumed Phenobarbitone) tab 15 mg (p’code 2647524)
  • Salbutamol (Teva-Salbutamol Sterinebs P.F.) nebuliser soln, 1 mg per ml, 2.5 ml ampoule – Up to 30 neb available on a PSO, s29 and wastage claimable (p’code 2674319)
  • Varicella zoster vaccine [shingles vaccine] (Shingrix) inj 50 mcg per 0.5 ml vial plus vial, 10 inj pack - only on a prescription, no patient co-payment payable and access criteria apply (p’code 2671921)

Changes to restrictions, chemical names and presentations

  • Dexamfetamine sulfate (PSM, Aspen and Noumed Dexamfetamine) tab 5 mg – addition of brand switch fee
  • Digoxin (Lanoxin Paediatric Elixir) oral liq 50 mcg per ml, 60 ml – removal of s29 and wastage claimable
  • Ethinyloestradiol with norethisterone (Brevinor 1/28, Brevinor-1 28 Day and Norimin-1 28 Day) tab 35 mcg with norethisterone 1 mg and 7 inert tab – reinstate stat dispensing
  • Glycomacropeptide and amino acid contains some phenylalanine (PKU GMPro Ultra Lemonade) powder (Lemonade) 33.4 g sachets – moved chemical to new therapeutic group
  • Hyoscine hydrobromide (Scopoderm TTS and Scopolamine – Mylan) patch 1 mg per 72 hours – amended presentation description
  • Methylphenidate hydrochloride extended-release tab extended release 18 mg, 27 mg, 36 mg and 54 mg (Concerta) and cap modified-release 10 mg, 20 mg, 30 mg and 40 mg (Ritalin LA) – amended Special Authority criteria
  • Nivolumab inj 10 mg per ml, 4 ml vial and 10 ml vial (Opdivo) and inj 1 mg for ECP (Baxter) – amended Special Authority criteria
  • Omeprazole cap 10 mg (Omeprazole actavis 10), cap 20 mg (Omeprazole actavis 20) and cap 40 mg (Omeprazole actavis 40) – removal of stat dispensing
  • Paclitaxel (Paclitaxel Ebewe, Anzatax and Paclitaxel Actavis) inj 6 mg per ml, 16.7 ml vial and 50 ml vial – amended presentation description
  • Pembrolizumab inj 25 mg per ml, 4 ml vial (Keytruda) and inj 1 mg for ECP (Baxter) – amended Special Authority criteria
  • Sacubitril with valsartan tab 24.3 mg with valsartan 25.7 mg (Entresto 24/26), tab 48.6 mg with valsartan 51.4 mg (Entresto 49/51) and tab 97.2 mg with valsartan 102.8 mg (Entresto 97/103) – amended Special Authority criteria

Increased subsidy

Chemical

Presentation

Fully subsidised brands

Atomoxetine

Cap 10 mg

Cap 18 mg

Cap 25 mg

Cap 40 mg

Cap 60 mg

Cap 80 mg

Cap 100 mg

APO-Atomoxetine

Blood glucose test strips (visually impaired)

Blood glucose test strips, 50 test OP

SensoCard

Goserelin

Implant 3.6 mg, syringe

Implant 10.8 mg, syringe

Teva

Decreased subsidy

Chemical

Presentation

Fully subsidised brands

Paclitaxel

Inj 6 mg per ml, 50 ml vial

Inj 1 mg for ECP

Anzatax

Baxter

Vincristine sulphate

Inj 1 mg per ml, 1 ml vial

DBL Vincristine Sulfate